Location History:
- Gimpo-si, KR (2017 - 2021)
- Hwaseong-si, KR (2018 - 2021)
- Gyeonggi-do, KR (2023)
Company Filing History:
Years Active: 2017-2025
Title: Sang Yun Kim: Innovator in Biopharmaceuticals
Introduction
Sang Yun Kim is a prominent inventor based in Gimpo-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, holding a total of 10 patents. His work focuses on innovative solutions that enhance therapeutic efficacy and patient outcomes.
Latest Patents
Among his latest patents are several groundbreaking inventions. One notable patent involves immunostimulating IL-2 analogs, which disclose modifications to interleukin-2 alpha receptors. Additionally, he has developed interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors. Another significant patent is for a lyophilized formulation of a long-acting human growth hormone immunoglobulin conjugate. This sustained release preparation contains a human growth hormone conjugate resulting from conjugation between an immunoglobulin Fc region and human growth hormone. The formulation includes a buffer solution, a nonionic surfactant, and a sugar alcohol. Furthermore, he has disclosed a freeze-dried preparation and a liquid preparation that includes the sustained release human growth hormone conjugate, along with methods for production and reconstitution.
Career Highlights
Sang Yun Kim has worked with notable companies such as Hanmi Pharmaceutical Co., Ltd. and Hyundai Motor Company. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the pharmaceutical and automotive industries.
Collaborations
Some of his coworkers include Sung Min Bae and Se Chang Kwon, who have collaborated with him on various projects. Their teamwork has fostered an environment of creativity and innovation.
Conclusion
Sang Yun Kim's contributions to biopharmaceuticals through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in medical therapies and improve patient care.